Creative Planning’s Juno Therapeutics, Inc. JUNO Stock Holding History

Creative Planning’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,000	Closed	-$30K	–	2187
2017 Q4	$30K	Buy	+10,000	New	+$499K	﹤0.01%	1837

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Creative Planning's JUNO Position: Q1 2018 in Review

Creative Planning sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 60,649 shares — an estimated $2.77M sold.

Creative Planning first reported a position in JUNO in Q4 2014 and held it in 12 quarters. The position peaked at $2.78M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Creative Planning reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Creative Planning sold 60,649 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $2.77M.
Creative Planning first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 12 quarters.
Creative Planning's Juno Therapeutics, Inc. position peaked at $2.78M in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Creative Planning's 13F filing for Q1 2018, filed 18 Apr 2018.